The cardiac troponins (cTns), cTnT and cTnI, are currently regarded as being the most useful diagnostic and prognostic biochemical mark ers of myocardial damage in patients with sus pected acute coronary syndromes (ACSs). In spite of the evidence-based nature of this observation, the uptake of serum cTn mea surement in routine clinical practice - in both the UK and elsewhere, is patchy; indeed, there still exists wide variability in the range of test ing and sampling strategies involving usage of the many existing cardiac markers. For evaluat ing suspected acute myocardial infarction (AMI) and other ACSs, international opinion favours either serum cTnT or cTnI (measured 12-24 h after admission to the emergency room) - together with a short-time window marker such as serum creatine kinase (CK) (measured on admission and perhaps again within the 12-24 h window). Translation of this strategy into universal clinical practice would require not only formulation of, but also strict adherence to, agreed clinical decision- making protocols which, in turn, would need to be backed by adequate funding.
Apple F.S. and Henderson A.R. (1999). Cardiac Function. In: Tietz Textbook of Clinical Chemistry, pp. 1178-1203 (by C A Burtis and E R Ashwood). Philadelphia, London and Toronto: W B Saunders Company
3.
Bailey L.M., Stott A., Manning E M C and Squire C.R. (1999). Cardiac Markers in Thyroid Disease. Proceedings of the National Meeting of the Association of Clinical Biochemists, 17-21 May1999, p. 69
4.
Banerjee S., Straffen A. and Rhoden W.E. (1997). Value of qualitative troponin T estimation in decision making in patients with chest pain. Brit J Cardiol ; 4(10), 414-418
5.
Chen Y.N., Wei J.R., Zeng L.J. and Wu M.Y. (1999). Monitoring of cardiac troponin I in patients with acute heart failure. Ann Clin Biochem; 36, 433-437
6.
Christenson R.H., Newby L.K. and Ohman E.M. (1997). Cardiac markers in the assessment of acute coronary syndromesMaryland Med J; Suppl, 18-24
7.
Collinson P.O. (2000). Cardiac markers into the new millennium. Ann Clin Biochem; 37, 109-113
8.
Galvani M., Ferrini D., Puggioni R., Ruggeri S. and Ottani F. (1998). New markers for early diagnosis of myocardial infarction. Int J Cardiol; 65(S), 17-22
9.
Gerhardt W. and Ljungdahl L. (1998). Troponin T: a sensitive diagnostic and prognostic marker of myocardial damage. Clin Chim Acta; 272(10), 45-57
10.
Glatz J.F., Van Der Vusse, Simoons M.L., Kragten J.A., Van Dieijen-Visser M.P. and Hermans W.T. (1998). Fatty acid-binding protein and the early detection of acute myocardial infarction. Clin Chim Acta; 272(1), 87-92
11.
Hartmann F., Kampmann M., Frey N., Muller-Bardorff M. and Katus H.A. (1998). Biochemical markers in the diagnosis of coronary artery disease. Euro Heart J; 19(S), 2-7
12.
Heeschen C., Hamm C.W., Goldmann B., Deu A., Langenbrink L. and White H.D. for the PRISM STUDY INVESTIGATORS (1999). Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. Lancet; 354, 1757-1762
13.
Hooper J. and Bangert S.K. (1995). Clinical Biochemistry in the Investigation of Acute Chest Pain and the Acute Abdomen. In: Clinical Biochemistry, Metabolic and Clinical Aspects, pp. 779-787 (by W J Marshall and S K Bangert). New York, Edinburgh and London: Churchill Livingstone
14.
Lindahl B., Venge P. and Wallentin L. (1997). Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in unstable coronary artery disease (FRISC) study group. J Am Coll Cardiol; 29, 43-48
15.
Mair J. ( 1997). Progress in myocardial damage detection: new biochemical markers for clinicians. Crit Rev Clin Lab Sci; 34(1), 1-66
16.
Moss D.W. and Henderson A.R. (1999). Clinical Enzymology. In: Tietz Textbook of Clinical Chemistry, pp. 617-721 (by C A Burtis and E R Ashwood). Philadelphia, London and Toronto: W B Saunders Company
17.
Newby L.K., Christenson R.H., Ohman E.M., Armstrong P.W., Thompson T.D., Lee K.L., et al (1998). Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators. Circulation, 98(18), 1853-1859
18.
Norris R.M., Johnson R.N., White H.D. and Robinson D.R. (1996). Non-invasive diagnosis of infarct artery patency after acute myocardial infarction by use of serial plasma troponin T concentrations: importance of measurement of peak levels. Heart; 75, 481-485
19.
Ohman E.M., Armstrong P.W., White H.D., Granger C.B., Wilcox R.G., Weaver W.D., et al (1999). Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTO-III Investigators. Global use of strategies to open occluded coronary arteries . Am J Cardiol; 84(11), 1281-1286
20.
Panteghini M., Apple F.S., Christenson R.H., Dati F., Mair J. and Wu A.H. ( 1999). Proposals from IFCC Committee on Standardisation of Markers of Cardiac Damage (C-SMCD): recommendations on the use of biochemical markers of cardiac damage in acute coronary syndromes. Scand J Clin Lab Invest; 59(S230), 103-112
21.
Plebani M. and Zaninotto M. (1999). Cardiac markers: present and future. Int J Clin Lab Res; 29(2), 56-63
22.
Rao A.C., Collinson P.O., Canepa-Anson R. and Joseph S.P. (1998). Troponin T measurement after myocardial infarction can identify left ventricular ejection of less than 40%Heart; 80(3), 223-225
23.
Rice M.S. and Macdonald D.C. (1999). Appropriate roles of cardiac troponins in evaluating patients with chest pain. J Am Board Fam Pract; 12(3), 214-218
24.
Wald D.S., Murphy C.F., Quiney J. and Reid C.J. (2000). How useful is troponin T in deciding the management of patients admitted to hospital with chest pain?Br J Cardiol;7(5), 272-276
25.
Why H. ( 2000). Biochemical markers of myocardial damage - useful or useless?Ass Clin Pathologists Yearbook; 27-28
26.
Willging S., Keller F. and Steinbach G. (1998). Specificity of cardiac troponins I and T in renal disease. Clin Chem Lab Med; 36(2), 87-92
27.
Wu A.H. ( 1998). Analyrtical and clinical evaluation of new diagnostic tests for myocardial damage. Clin Chim Acta; 272(1), 11-21
28.
Wu A.H. ( 1999). Biochemical markers of cardiac damage: from traditional enzymes to cardiac-specific proteins. IFCC Subcommittee on Standardisation of Cardiac Markers (S-SCM). Scand J Clin Lab Invest; 230(S), 74-82
29.
Wu A H B, Apple F.S., Gibler W.B., Jesse R.L., Warshaw M.M. and Valdes R. (1999). National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem; 45, 1104-1121
